GSK plc banner

GSK plc
F:GS71

Watchlist Manager
GSK plc Logo
GSK plc
F:GS71
Watchlist
Price: 22.1 EUR -0.27% Market Closed
Market Cap: €90.1B

Wall St Price Targets

GS71 Price Targets Summary
GSK plc

Wall Street analysts forecast GS71 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GS71 is 24.62 EUR with a low forecast of 16.83 EUR and a high forecast of 33.06 EUR.

Lowest Forecast
Price Target
16.83 EUR
24% Downside
Average Forecast
Price Target
24.62 EUR
11% Upside
Highest Forecast
Price Target
33.06 EUR
50% Upside
GSK plc Competitors:
Price Targets
SMG
Scotts Miracle-Gro Co
21% Upside

Revenue
Forecast

2% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 5%.

Gross Profit
Forecast

2% / Year
Past Growth
7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 7%.

Operating Income
Forecast

2% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 5%.

Pre-Tax Income
Forecast

1% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
1% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 14%.

Net Income
Forecast

2% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 14%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GS71's stock price target?
Price Target
24.62 EUR

According to Wall Street analysts, the average 1-year price target for GS71 is 24.62 EUR with a low forecast of 16.83 EUR and a high forecast of 33.06 EUR.

What is the Revenue forecast for GSK plc?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 5%.

What is the Gross Profit forecast for GSK plc?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 7%.

What is the Operating Income forecast for GSK plc?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 5%.

What is the Pre-Tax Income forecast for GSK plc?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 14%.

What is the Net Income forecast for GSK plc?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 14%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett